R. Lucas (Konstanz, Germany), A. Hamzaoui (Ariana, Tunisia)
Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis M. Ohmori, M. Kataoka, H. Ichikawa, W. Ito, Y. Tanimoto, A. Kanehiro, M. Tanimoto (Okayama City, Japan)
| |
Promoters and inhibitors m-RNAs expression before and after treatment with interferon gamma-1b or colchicine in idiopathic pulmonary fibrosis: preliminary results K. Antoniou, M. Zervou, E. Tzortzaki, M. Dimadi, P. Latsi, V. Polychronopoulos, N. M. Siafakas, D. Bouros (Heraklion, Athens, Greece)
| |
Intraalveolar levels of tenascin C and thrombin-activatable fibrinolysis inhibitor in interstitial lung diseases H. Fujimoto, E. C. Gabazza, Y. Nishii, C. N. D'Alessandro-Gabazza, O. Hataji, T. Yoshida, Y. Adachi, O. Taguchi (Tsu, Japan)
| |
Correlation between tenascin C and tissue factor in patients with interstitial lung disease O. Hataji, E. C. Gabazza, Y. Nishii, C. N. D'Alessandro-Gabazza, T. Yoshida, Y. Adachi, O. Taguchi (Tsu, Japan)
| |
Hemostasis disorders and their correction using ticlopidine in patients with cryptogenic fibrosing alveolitis (CFA) S. N. Vasilev, B. F. Serebraynaya, G. O. Kaminskaya, I. E. Stepanayn, E. I. Shmelev (Moscow, Russia)
| |
Coagulation activity of bronchoalveolar lavage fluid and blood is dependent on pulmonary sarcoidosis stage J. Talalaj, E. Chyczewska, M. Korniluk, M. Ossolinska (Bialystok, Poland)
| |
Is there correlation between the BAL and induced sputum principal phospholipids level in sarcoidosis? H. L. Baradzina, I. L. Kotovich, A. D. Taganovich (Minsk, Belarus)
| |
Vascular endothelial growth factor (VEGF) isoform expression in primary human cultured alveolar epithelial cells A. R. L. Medford, S. I. H. Godinho, L. Armstrong, K. M. Uppington, D. O. Bates, S. J. Harper, A. B. Millar (Bristol, United Kingdom)
| |
Decreased heme oxygenase (HO) - 1 in induced sputum of smokers with chronic obstructive pulmonary disease (COPD) G. Guarnieri, Y. Nowicki, S. Menato, E. Marian, P. Boschetto, C. Mapp, P. Maestrelli (Padova, Ferrara, Italy)
| |
Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease J. Pons, J. Sauleda, J. M. Ferrer, V. Regueiro, B. Barcelo, A. Fuster, A. G. N. Agusti (Palma de Mallorca, Spain)
| |
Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease B. Barcelo, A. Fuster, J. Pons, J. Sauleda, J. Ferrer, C. Santos, A. G. N. Agusti (Palma de Mallorca, Spain)
| |
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? H. Batura-Gabryel, A. Szczepanik (Poznan, Poland)
| |
Cigarette smoke can increase the neutrophil recruitment in the airways of COPD patients by increasing PGE2 release in alveolar macrophages (AM) M. Profita, A. Sala, A. Bonanno, R. Di Giorgi, L. Riccobono, M. R. Melis, E. Pace, G. Bonsignore, A. M. Vignola (Palermo, Milan, Italy)
| |
Mesothelioma cells counteract talc toxicity by prostaglandin E2 (PGE2) E. Pace, M. Profita, M. R. Melis, A. Bonanno, A. M. Vignola, C. H. Mody, A. Tipa, M. Ferraro, M. Spatafora, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Calgary, Canada)
| |
Adhesion molecules LFA-1(CD11a), Mac-1(CD11b), ICAM-1l(CD54) of T-lymphocytes, IL-1β, IL-1ra and IL-4 in serum of patients with inflammatory diseases of the lower respiratory tract A. Chcialowski, T. Plusa, W. Lubinski, E. Pirozynska, W. Stankiewicz, S. Dudko, R. Carewicz, M. Dabrowski (Warsaw, Poland)
| |